Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study

INTRODUCTION: Immunotherapy is a well-established treatment option in patients with metastatic melanoma. However, biomarkers that can be used to predict a response in these patients have not yet been found, putting patients at risk of severe side effects. METHODS: In this retrospective analysis, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Richtig, Georg, Hoeller, Christoph, Wolf, Martin, Wolf, Ingrid, Rainer, Barbara M., Schulter, Günter, Richtig, Markus, Grübler, Martin R., Gappmayer, Anna, Haidn, Thomas, Kofler, Julian, Huegel, Rainer, Lange-Asschenfeldt, Bernhard, Pichler, Martin, Pilz, Stefan, Heinemann, Akos, Richtig, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166940/
https://www.ncbi.nlm.nih.gov/pubmed/30273398
http://dx.doi.org/10.1371/journal.pone.0204729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166940/
https://www.ncbi.nlm.nih.gov/pubmed/30273398
http://dx.doi.org/10.1371/journal.pone.0204729

Ejemplares similares